http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104130303-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H23-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 |
| filingDate | 2014-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104130303-B |
| titleOfInvention | A kind of cobamamide compound and pharmaceutical composition thereof |
| abstract | The invention discloses cobamamide compound, its X ray powder diffraction is as shown in Figure 1.The invention also discloses the pharmaceutical composition of cobamamide compound.The cobamamide stable chemical nature of the present invention, the good stability of this compound, it is possible to there is higher effect at treatment nervous system disease.And the component of cobamamide compositions of the present invention is simple, safety good, the injection cobamamide lyophilizing character uniform and smooth of preparation, solubility is good, good stability. |
| priorityDate | 2014-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.